WO2002074161A2 - Subcutaneous analyte sensor - Google Patents
Subcutaneous analyte sensor Download PDFInfo
- Publication number
- WO2002074161A2 WO2002074161A2 PCT/EP2002/002960 EP0202960W WO02074161A2 WO 2002074161 A2 WO2002074161 A2 WO 2002074161A2 EP 0202960 W EP0202960 W EP 0202960W WO 02074161 A2 WO02074161 A2 WO 02074161A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- light
- analyte
- membrane
- optical
- assembly
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
Definitions
- the present invention relates to implantable sensors, and more specifically, to implantable sensors for monitoring levels of analytes, such as glucose.
- European patent 0 074428 describes a method and device for the quantitative determination of glucose by laser light scattering.
- the method assumes that glucose particles scatter light rays transmitted through a test solution, and that the glucose concentration can be derived from this scattering.
- the method requires measurement of the spatial angular distribution of the transmitted (i.e. forward-scattered) light emerging from a test cuvette or an investigated part of the body.
- the intensity of the transmitted light is measured in an angular region in which the change in relation to the glucose concentration is as large as possible. This intensity is then compared with the intensity measured for the central ray passing directly through the sample.
- a transmission measurement on ear lobes with laser light is exclusively recommended.
- a second method based on light scattering principles relies on the measurement of back- scattered light rather than transmitted (i.e. forward-scattered) light.
- U.S. Pat. No. 5,551,422 describes a method for determining glucose concentration in a biological matrix by performing at least two detection measurements. In each detection measurement, primary light is irradiated into the biological matrix through a boundary surface thereof at a defined radiation site. The light is propagated along a light path within the biological matrix. An intensity of the light is measured as the light emerges as secondary light through a defined detection site of the boundary surface. At least one of the detection measurements is a spatially resolved measurement of multiply scattered light.
- the detection site is located relative to the irradiation site such that light which was multiply scattered at scattering centers in the biological matrix is detected.
- the light paths of the at least two detection measurements within the biological matrix are different.
- Glucose concentration is then derived from the dependence of the intensity of the secondary light on the relative positions of the irradiation site and the detection site.
- the present invention in another form thereof, comprises an implantable optical- sensing element suitable for measuring the concentration of an analyte in a biological matrix.
- the optical-sensing element comprises a body, and a membrane mounted on the body such that the body and the membrane define a cavity for receiving the analyte.
- the membrane is substantially permeable to the analyte, and substantially impermeable to background species in the biological matrix, such as large proteins.
- a refractive element having a refractive index different from the refractive index of the analyte is disposed in the cavity.
- a light source provides light into each of the first and second cavities toward the respective first and second refractive elements, and a light detector receives light from each of the first and second cavities.
- a signal processor and computer are provided to relate the respective intensities of the provided light and the received light to the analyte concentration.
- the present invention in still another form thereof, comprises an implantable optical- sensing element suitable for measuring the concentration of an analyte in a biological matrix.
- the optical-sensing element comprises a body and a first semi-permeable membrane mounted on the body.
- the first membrane is permeable to the analyte, and impermeable to background species in the biological matrix.
- the first membrane and the body are aligned to define a first cavity, the first cavity having a first refractive element disposed therein.
- a second membrane is mounted on the body remote from the first membrane.
- the second membrane and the body are aligned to define a second cavity isolated from the first cavity, the second cavity having a second refractive element disposed therein.
- the present invention in yet another form thereof, comprises a method for measuring the concentration of an analyte in a biological matrix.
- An optical-sensing element is implanted in the biological matrix, the optical-sensing element comprising a body and a semi-permeable membrane mounted on the body, the semi-permeable membrane being permeable to the analyte and impermeable to background species in the matrix.
- the semi-permeable membrane and the body define a cavity, and a refractive element is disposed in the cavity.
- Primary light from a light-emitting source is introduced into the body of the optical-sensing element, and is directed toward the refractive element.
- the present invention in another form thereof, comprises a method for measuring the concentration of an analyte in a biological matrix.
- An optical-sensing element is implanted in the biological matrix, the optical-sensing element comprising a body, a first semi-permeable membrane mounted on the body, and a second semi-permeable membrane mounted on the body remote from the first semi-permeable membrane.
- the body and the first membrane define a cavity having a first refractive element disposed therein, and the body and the second membrane define a second cavity isolated from the first cavity and having a second refractive element disposed therein.
- Primary light from a light-emitting source is transmitted into the body, and respective streams of the primary light are directed into the first cavity toward the first refractive element, and into the second cavity toward the second refractive element.
- Light reflected from the first refractive element is collected and transmitted to a first channel of a light-detecting device, and light from the body reflected at the second refractive element is collected and transmitted to a second channel of the light-detecting device.
- the respective intensities of light collected from each of the first and second channels is measured, and the concentration of an analyte in the biological matrix is computed by comparing the intensity of the transmitted light and the light collected from each of the first and second channels.
- the present invention in yet another form thereof, comprises an assembly for monitoring the concentration of an analyte in a biological matrix.
- the assembly includes an implantable optical-sensing element that comprises a body, a membrane mounted on the body, and a refractive element disposed in a cavity defined by the membrane and the body.
- the analyte is received in the cavity through the membrane, wherein the membrane is substantially permeable to the analyte of interest and substantially impermeable to background species in the biological matrix.
- One or more light sources provide light of a first wavelength and a second wavelength into the cavity, the refractive element in the cavity having a refractive index greater than the refractive index of the analyte at the first wavelength, and less than the refractive index of the analyte at the second wavelength.
- a detector receives from the cavity an intensity of light at each of the first and second wavelengths at a first concentration of said analyte, and receives an intensity of light at each of the first and second wavelengths at a second concentration of the analyte.
- a signal-processing and computing element is optically coupled to the detector for comparing the intensities of light received at the first wavelength to the intensities of light received at the second wavelength, and for relating the intensities to analyte concentration.
- Figure 2 shows a front cross-sectional view through the XjY plane of the optical- sensing element illustrated in Figure 1;
- Figure 3 shows a shows a top cross-sectional view through the XjZi-plane of the optical- sensing element illustrated in Figure 1;
- Figure 5 shows a front cross-sectional view through the X 2 Y 2 -plane of the optical - sensing element illustrated in Figure 4;
- Figure 6 shows a top cross-sectional view through the X 2 Z 2 -plane of the optical-sensing element illustrated in Figure 4;
- Figure 7 shows a side cross-sectional view through the Y 3 Z 3 -plane of an optical- sensing element according to a third embodiment of the present invention
- Figure 8 shows a front cross-sectional view through the X 3 Y 3 -plane of the optical- sensing element illustrated in Figure 7
- Figure 9 shows a top cross-sectional view through the X 3 Z 3 -plane of the optical-sensing element illustrated in Figure 7;
- Figure 11 shows a top cross-sectional view through the X Y -plane of the optical-sensing element illustrated in Figure 10;
- Figure 12 shows a front cross-sectional view through the X 4 Z -plane of the optical- sensing element illustrated in Figure 10;
- Figure 14 shows a side cross-sectional view through the X 5 Ys-plane of the optical- sensing element illustrated in Figure 13;
- Figure 16 shows a side cross-sectional view through the Y 6 Z 6 -plane of an optical-sensing element according to a sixth embodiment of the present invention
- Figure 19 shows a side cross-sectional view through the Y 7 Z 7 -plane of an optical-sensing element according to a seventh embodiment of the present invention
- Figure 23 shows another block diagram of the an opto-electronic detection and measurement assembly optically coupled to an optical-sensing element of the type described in embodiments 1-5;
- biological matrix denotes a body fluid or a tissue of a living organism.
- Biological matrices, to which the invention relates are optically heterogeneous, that is, they contain a large number of substances (e.g., salts, proteins, and organic acids) which can affect the refractive index.
- mMol denotes the concentration of a substance in units of millimoles per liter.
- n denotes the refractive index of a substance.
- the present invention provides an assembly comprising an implantable optical-sensing element suitable for measuring the concentration of an analyte in a biological matrix.
- the function of the optical-sensing element is to generate changes in light refraction, which changes are a function of changes in the concentration of the analyte in the biological matrix.
- the optical-sensing element includes a membrane mounted on a body, such that the membrane and the body define a cavity.
- the membrane is substantially permeable to the analyte, thereby permitting the analyte to pass through the membrane and into the cavity by means such as diffusion or osmosis, and is substantially impermeable to background species in the biological matrix.
- the optical-sensing element of the present invention is stable over extended periods of time, does not require frequent recalibration, and does not require signal amplification through enzymatic reactions.
- the optical-sensing element also minimizes or eliminates background drift in such measurements due to variations in physical parameters such as temperature and/ or changes in the concentrations of background ions, proteins, and organic acids that may be present in the biological matrix.
- an analyte suitable for monitor utilizing the assembly of the present invention is glucose. It is well known that a change in concentration of an analyte, such as glucose, in a test solution results in a change in the refractive index of the solution.
- the present invention addresses this problem by providing an optical-sensing element having a substantially impermeable body that is enclosed on at least one surface thereof by a semi-permeable membrane.
- the semi-permeable membrane is designed to exclude undesired background molecules and/ or ions from entering/exiting the interior of the body, while allowing the analyte or analytes of interest to freely diffuse through the membrane.
- the analyte of interest is glucose
- the glucose diffuses through the membrane to equilibrate with tissue glucose concentration.
- Background species cannot permeate through the membrane.
- proteins can be excluded by using membranes with adequate pore size (e.g., 30kD to exclude albumin but enable glucose diffusion), and ions can be excluded by using a polarized membrane (+/-) layer.
- Suitable bipolar membranes for use in the present invention include those produced by Tokuyama Soda (Japan) under the trade name of NeoSepta, available from Electrosynthesis Company, Lancaster, NY. These membranes are produced for bulk electrolysis and salt-splitting applications, and thus are mechanically very stable and rigid. They possess the high charge densities required for use in the high salt concentrations of biological matrices. These membranes are approximately 250 um in thickness, and maybe cut to any appropriate size. Thinner membranes of lower ionic content could also be used. Thinner membranes are advantageous because they decrease the response time of the sensor and may provide more accurate results.
- a thinner bipolar membrane is used to enable a more rapid response time, it may be desirable to combine the bipolar membrane with a third membrane layer capable of excluding macrosolutes.
- a third membrane layer may, for example, be any of the membranes typically used for dialysis applications, such as regenerated cellulose or polyamide membranes.
- the third membrane layer may be attached to the sensor body, on or around the bipolar membrane, using any of the methods suitable for attaching the bipolar membrane.
- the third membrane layer may be laminated directly to the bipolar membrane prior to application of the bipolar-membrane to the sensor body.
- the third membrane layer may be formed on the bipolar membrane by a casting process, for example, by dipping the assembled optical-sensing element with bipolar membrane attached into a solution of a membrane- forming polymer, and then drying the element under controlled conditions.
- Bipolar membranes can be formed into hollow fibers in the same way that membranes for dialysis and microdialysis are produced, and the membrane fibers slid over the sensor structure and attached with any of the above methods.
- the sensitivity of the measurement is optimized when the refractive index of a refractive element disposed within the body, and the refractive index of an analyte such as glucose are preferably within 9%, more preferably within 5%, of each other when the glucose concentration in the biological matrix is at physiological levels, i.e., between 4 and 7 mMol.
- the body 100 of the optical-sensing element has a generally "U” or “V"- shaped cross-section, and comprises a molded plastic.
- the body 100 has a base portion 101 and two opposing side walls 103. Each of the side walls 103 includes an upper edge 111.
- the body 100 has a proximal end 102 and a distal end 104, and is preferably less than 2 mm in length.
- a light-transmitting conduit 106 here a single optical fiber, is optically coupled to the proximal end 102 of the body.
- Optical coupling between the body and the conduit can be accomplished by any means known in the art, such as, for example, using an adhesive to secure the conduit 106 in an orifice formed in the body 100.
- the body 100 of the optical-sensing element provides a support structure for the optical-sensing element and should correspondingly be rigid or semi-rigid. Since the sensing element is designed to be implanted in living tissue, the construction material of the body 100 should also be bio-compatible.
- the distal end 104 of the body 100 preferably comprises a light absorbing material 108, although a transparent material may alternatively be utilized.
- the refractive element 114 can comprise a single structure or a plurality of structures. No particular shape is required. Examples of single structures include a porous fiber, a porous rod, a convoluted ribbon, and a convoluted fiber. The refractive element may also comprise combinations of the foregoing. Examples of pluralities of structures include regular or randomly shaped plates, particles, beads and powders, or combinations of the foregoing. Regardless of the particular embodiment, the refractive element preferably provides a plurality of reflective or refractive faces 115 that interface with the analyte to amplify the reflected light when compared to light reflected from a single surface.
- the body 200 of the optical-sensing element comprises two parallel, elongated members 203, each having an upper edge 211 and a lower edge 213.
- the body is preferably formed of molded plastic and is dimensioned in similar manner to the embodiment of Figs. 1-3.
- the body 200 also includes a proximal end 202 and a distal end 204.
- a light-transmitting conduit 206 here a single optical fiber, is sealed in an orifice in the proximal end 202.
- the distal end 204 preferably comprises a light-absorbing material 208.
- a first semi-permeable membrane 210 is attached to the top edges 211 of the elongated members 203, and a second semi-permeable membrane 209 is attached to the bottom edges 213 of the elongated members 203.
- the elongated members 203 and semi-permeable membranes 209 and 210 define a cavity 212.
- the cavity contains the analyte of interest (not shown) and a refractive element 214.
- the refractive element comprises a plurality of substantially parallel, rectangular plates, and the elongated members 203 are held together with cross-support from the rectangular plates.
- the numbers and orientation of rectangular plates 214 and faces 215 are similar to those as described in the previous embodiment.
- a fourth embodiment of the invention is illustrated in Figures 10-12.
- the body 400, base portion 401, side walls 403, light-transmitting conduit 406, light-absorbing material 408, membrane 410, edges 411, cavity 412, and respective proximal and distal ends 402 and 404 are as described in the embodiment of Figs. 1-3.
- the refractive element 414 comprises a convoluted ribbon or fiber, which provides a plurality of reflective or refractive surfaces 415.
- the composition, length, width, and - thickness of the ribbon 414 can be varied to achieve a packing arrangement which gives optimal amplification of light by multiple reflections off the surfaces 415.
- the particular composition of the ribbon or fiber is normally not important, as long as suitable reflective or refractive surfaces are provided. Glass or plastic ribbons and fibers are particularly suitable.
- the refractive elements preferably are made from the same material as the body 600 and comprise a plurality of substantially parallel, rectangular plates as before.
- the first and second light-absorbing materials, 608 and 618 respectively, preferably have the same composition.
- the second semi-permeable membrane 620 may have the same composition as its counterpart in the first cavity 612, or a different composition.
- the distal end 704 of the body 700 preferably comprises a first light- absorbing material 708 adjacent the first cavity 712.
- the first cavity 712 contains a first refractive element 714.
- the first refractive element 714 is preferably made from the same material as the body 700, and comprises a plurality of substantially parallel, rectangular plates.
- the second refractive element 724 is preferably made from the same material as the body 700, and comprises a plurality of substantially parallel, rectangular plates.
- the first and second light- absorbing materials, 708 and 718 respectively, preferably have the same composition.
- the second semi- permeable membrane 720 may independently have the same composition as its counterpart in the first cavity 712, or a different composition.
- the sixth and seventh embodiments of this invention are particularly useful for simultaneously measuring the concentration of two different analytes in a biological matrix. This maybe accomplished by choosing respective semi-permeable membranes that are permeable to different species.
- the first semi-permeable membrane could be permeable to analyte A but impermeable to analyte B, while the second semi-permeable membrane could be permeable to analyte B but impermeable to analyte A.
- the first cavity would then be used to monitor the concentration of analyte A, while the second cavity would be used to monitor the concentration of analyte B.
- the sixth and seventh embodiments of this invention may also be useful for correcting for background changes in the refractive index of a biological matrix resulting from variations in physical parameters like temperature.
- the first semi- permeable membrane could be permeable to only analyte A, while the second semi- permeable membrane could be impermeable to all of the components (analytes) of the biological matrix.
- the first cavity would then constitute a sample cell, while the second cavity would constitute a reference cell.
- the sample cell could be used to monitor changes in light resulting from changes in the concentration of analyte A and physical changes in the environment of the sensing element.
- the reference cell could be used to monitor changes in light intensity resulting solely from physical changes in the environment of the biological matrix. The differences in light intensity between the sample and reference cells would then correlate to the change in refractive index of the biological matrix due solely to a change in concentration of analyte A.
- the first semi-permeable membrane could be permeable to analyte A and background species in the biological matrix, while the second semi-permeable membrane could be permeable to the background species but impermeable to analyte A.
- the first cavity would still constitute a sample cell, while the second cavity would constitute a reference cell.
- the sample cell would now be used to monitor changes in light intensity resulting from changes in the concentration of analyte A, physical changes in the environment of the sensing element, and changes in the concentration of the background species.
- the reference cell would be used to monitor changes in light intensity resulting from physical changes in the environment of the sensing element and changes in the concentration of the background species.
- the implantable analyte sensor of the present invention is designed to optically couple with an opto-electronic detection and measurement assembly.
- the opto-electronic detection and measurement assembly may include the light source for transmitting light from the light source to the sensing element, or alternatively, the light source may comprise a separate assembly.
- the opto-electronic detection and measurement assembly includes a detector for receiving light that has been returned or otherwise reflected from the sensing element.
- a signal-processing and computing element is optically coupled to the detector to compare the intensity of the received light to that of the transmitted light. By using previously measured reference values, the signal- processing and computing element converts the differences in light intensity to a signal relating to analyte concentration. The signal can then be displayed on a readout device.
- LEDs laser diodes, xenon and metal halide lamps, can be used as the light source.
- FIG. 22 A block diagram of an opto-electronic detection and measurement assembly optically coupled to an optical-sensing element of the type described in embodiments 1-5 is shown in Figure 22.
- the first end 802 of a first light-transmitting conduit 800 is optically coupled to the proximal end 806 of the body of the optical-sensing element
- the second end 804 of the first light-transmitting conduit 800 is optically coupled to both a light- emitting source and a light-detecting device.
- optical coupling is provided by a beam-splitter 810.
- the beam-splitter is preferably tilted such that the angle of incoming light is equal to the angle of reflected light, and is oriented such that secondary light emitted from the second end 804 of the first light-emitting conduit 800 is directed into a second light-transmitting conduit 814 connected to a light-detecting device.
- the light- detecting device can be, for example, a photomultiplier tube or a photodiode.
- the beam-splitter 810 is also oriented such that primary light emitted from a third light-transmitting conduit 812 connected to the light- emitting source is directed into the second end 804 of the light- transmitting conduit 800.
- the source can emit light either continuously or in a pulsed mode. Suitable light sources and detectors can be purchased from Hamamatsu Corporation, Bridgewater NJ.
- the light-detecting device is electrically coupled to a signal-processing and computing element which converts the secondary light to an electronic signal that can be read in conventional fashion, such as by visual display on a conventional readout device.
- the signal-processing and computing element may comprise, for example, a conventional controller such as a software-driven computer.
- each of the first, second, and third light-transmitting conduits, 800, 814, and 812 respectively, comprises one or more optical fibers.
- Suitable optical fibers and optical fiber bundles can be purchased from Polymicro Technologies, LLC of Phoenix, AZ.
- Suitable beamsplitters for optical fibers can be purchased from Oz Optics LTD. of Carp, Ontario, Canada.
- first end 912 of a second light-transmitting conduit 910 which is optically coupled to the proximal end 906 of the body of the optical-sensing element.
- the second end of the conduit 914 is optically coupled to a light-detecting device, for example using an SMA connector.
- the light-detecting device can be, for example, a photomultiplier tube or a photodiode.
- each of the first and second light- transmitting conduits, 900 and 910 respectively, comprises one or more optical fibers.
- the light-detecting device is electrically coupled to a signal-processing and computing element, which converts the secondary light to an electronic signal, which can be displayed on a readout device.
- FIG. 24 A block diagram of an opto-electronic detection and measurement assembly optically coupled to an optical-sensing element of the type described in embodiments 6-7 is shown in Figure 24.
- Primary light is emitted from a light- emitting source.
- the light- emitting source is optically coupled to the first end 922 of a first light- transmitting conduit 920.
- the second end 924 of the first light- transmitting conduit 920 is optically coupled to the proximal end 926 of the body of the optical-sensing element adjacent the first cavity, in an alignment such that the primary light is directed into the first cavity toward the first refractive element.
- Secondary light resulting from reflection or refraction at the first refractive element is collected in the first end 942 of a second light- transmitting conduit 940.
- the first end 942 of the second light-transmitting conduit 940 is optically coupled to the proximal end 926 of the body of the optical-sensing element adjacent the first cavity, while the second end 944 is optically coupled to a channel of a light-detecting device.
- the light-detecting device can be, for example, a photomultiplier tube or a photodiode.
- the light-emitting source is optically coupled to the first end 932 of a third light- transmitting conduit 930.
- the second end 934 of the third light- transmitting conduit 930 is optically coupled to the proximal end 926 of the body of the optical- sensing element adjacent the second cavity, in an alignment such that the primary light is directed into the second cavity toward the second refractive element. Secondary light resulting from reflection or refraction at the second refractive element is collected in the first end 952 of a fourth light-transmitting conduit 950.
- the invention further contemplates a method of measuring the concentration of an analyte in a biological matrix.
- an optical-sensing element is inserted in the matrix.
- the optical-sensing element includes a body, a semi-permeable membrane and a refractive element as described previously.
- primary light is transmitted from a light- emitting source to the body of the optical-sensing element, and directed into the cavity to the refractive element.
- secondary light resulting from the reflection or refraction of the light at the refractive element is collected and read by a light- detecting device.
- the difference in intensity between the transmitted light and the reflected light is measured by a standard computing device, and the analyte concentration in the biological matrix is determined by the computing device using, for example, an algorithm and calibration procedure.
- algorithm and calibration procedure are well known to those of ordinary skill in the art.
- changes in light intensity returned from the optical sensing component can be related to changes in the concentration of a specified analyte, such as glucose, in the biological matrix without the necessity of spectroscopic measurement at multiple wavelengths.
- a specified analyte such as glucose
- the principle relied on is light reflection, not optical absorption.
- the wavelength is preferably chosen in a region of the spectrum where absorption of the analyte is relatively low.
- the wavelength is between 400 nm and 1300 nm. Other wavelengths outside of this range may be utilized in suitable cases, provided that interfering species are not substantially present in the matrix, or if present, are compensated for by the use of proper reference test samples.
- these spectral regions need not normally be further narrowed to avoid interferences due to absorption by other components in the biological matrix (e.g., hemoglobin), since the semi-permeable membrane excludes such components from the sensing volume.
- other components in the biological matrix e.g., hemoglobin
- the semi-permeable membrane excludes such components from the sensing volume.
- there is no particular preference for relatively short wavelengths because the method does not depend on the depth of penetration of light into the biological matrix.
- absorption-based methods for noninvasive analytical determination of the glucose concentration in a biological matrix in the present invention it is generally not necessary to use narrow-band measurement, due to the minimal dependence on the measurement wavelength.
- relatively broad-banded light sources (with half- widths larger than 20 nm), such as light-emitting diodes (LED's) and other semi-conductor light sources, can be used without the need for subsequent spectral selection on the primary side or secondary side. This considerably reduces the cost of the apparatus.
- This feature makes the apparatus especially suitable for the continuous monitoring of the glucose concentration of a diabetic. Even though it is generally not necessary to use a laser as a primary light source, in some situations, such as with planar refractive surfaces, laser light may be utilized if desired. Similarly, it is generally not necessary to use coherent or polarized light.
- An alternative arrangement to that described above utilizes one or more light sources that emit light into the cavity at defined wavelengths in order to exploit the dispersion (i.e., wavelength-dependence) of the refractive indices of the refractive material and/or the analyte.
- a light source emits light having a wavelength ⁇ i at which the refractive index of the refractive element ⁇ e i ement is always greater than the refractive index of the analyte n ana i y te-
- Another light source emits light having a wavelength ⁇ 2 at which the refractive index of the refractive element n e i ement is always less than the refractive index of the analyte ⁇ ana i yte .
- a single light source that emits light at multiple wavelengths may be used in combination with a (dichroic) beam splitter to split the light into separate beams at the desired wavelengths.
- n ana i yte increases and therefore n ⁇ increases for both ⁇ i and ⁇ 2 .
- this arrangement can be used to improve the sensitivity and/or the specificity of the method.
- either a single detector or multiple detectors can be used. For example, when two wavelengths ⁇ j . and ⁇ 2 are used as described above, two separate detectors can be utilized to receive the signals. One detector would receive the " ⁇ i -light" and the other would receive the " ⁇ 2 - light".
- a wavelength-dependent dicroic beam splitter can be used to isolate the proper wavelength from the reflected light.
- a controller could then be utilized to analyze the signals by means such as signal subtraction to yield an analyte-dependent result.
- a single detector may also be utilized, however in this instance, the signals are generally received alternating in time.
- Suitable light sources for use in this multiple wavelength approach include multiple independent single light sources each having a different wavelength.
- a beam splitter may be utilized with a single, multichromatic light source to split the light into separate beams at different, well-defined wavelengths.
- the sensor could be designed as a transcutaneous sensor, which uses a light guide to transmit light to and from the optical-sensing element.
- the sensor could be an integrated device.
- the implanted device would incorporate the light- emitting and optical-sensing elements in a single element.
- a fully compatible sensor unit can also include RF data transmission means and a battery charge.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2440854 CA2440854C (en) | 2001-03-16 | 2002-03-18 | Subcutaneous analyte sensor |
EP02703638A EP1372466A2 (en) | 2001-03-16 | 2002-03-18 | Subcutaneous analyte sensor |
JP2002572876A JP3692116B2 (en) | 2001-03-16 | 2002-03-18 | Subcutaneous specimen sensor |
AU2002237332A AU2002237332A1 (en) | 2001-03-16 | 2002-03-18 | Subcutaneous analyte sensor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/810,635 | 2001-03-16 | ||
US09/810,635 US6952603B2 (en) | 2001-03-16 | 2001-03-16 | Subcutaneous analyte sensor |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002074161A2 true WO2002074161A2 (en) | 2002-09-26 |
WO2002074161A3 WO2002074161A3 (en) | 2003-07-24 |
Family
ID=25204303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/002960 WO2002074161A2 (en) | 2001-03-16 | 2002-03-18 | Subcutaneous analyte sensor |
Country Status (6)
Country | Link |
---|---|
US (3) | US6952603B2 (en) |
EP (1) | EP1372466A2 (en) |
JP (1) | JP3692116B2 (en) |
AU (1) | AU2002237332A1 (en) |
CA (1) | CA2440854C (en) |
WO (1) | WO2002074161A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9986942B2 (en) | 2004-07-13 | 2018-06-05 | Dexcom, Inc. | Analyte sensor |
US10524703B2 (en) | 2004-07-13 | 2020-01-07 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10610136B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10813577B2 (en) | 2005-06-21 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
US11102306B2 (en) | 2008-02-21 | 2021-08-24 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
Families Citing this family (220)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001067A (en) | 1997-03-04 | 1999-12-14 | Shults; Mark C. | Device and method for determining analyte levels |
US8527026B2 (en) | 1997-03-04 | 2013-09-03 | Dexcom, Inc. | Device and method for determining analyte levels |
US6862465B2 (en) | 1997-03-04 | 2005-03-01 | Dexcom, Inc. | Device and method for determining analyte levels |
US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6952603B2 (en) * | 2001-03-16 | 2005-10-04 | Roche Diagnostics Operations, Inc. | Subcutaneous analyte sensor |
AU2002309528A1 (en) | 2001-04-02 | 2002-10-15 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
AU2002315177A1 (en) | 2001-06-12 | 2002-12-23 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
EP1395185B1 (en) | 2001-06-12 | 2010-10-27 | Pelikan Technologies Inc. | Electric lancet actuator |
EP1404235A4 (en) | 2001-06-12 | 2008-08-20 | Pelikan Technologies Inc | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
JP4272051B2 (en) | 2001-06-12 | 2009-06-03 | ペリカン テクノロジーズ インコーポレイテッド | Blood sampling apparatus and method |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US7041068B2 (en) | 2001-06-12 | 2006-05-09 | Pelikan Technologies, Inc. | Sampling module device and method |
DE60239132D1 (en) | 2001-06-12 | 2011-03-24 | Pelikan Technologies Inc | APPARATUS FOR INCREASING THE SUCCESS RATE IN RESPECT OF BLOOD EXPLOITATION OBTAINED BY A FINGERSTICK |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US20030032874A1 (en) | 2001-07-27 | 2003-02-13 | Dexcom, Inc. | Sensor head for use with implantable devices |
AU2002358128A1 (en) * | 2001-12-17 | 2003-06-30 | Danfoss A/S | Method and device for monitoring analyte concentration by optical detection |
US7379765B2 (en) | 2003-07-25 | 2008-05-27 | Dexcom, Inc. | Oxygen enhancing membrane systems for implantable devices |
US7613491B2 (en) | 2002-05-22 | 2009-11-03 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US7828728B2 (en) | 2003-07-25 | 2010-11-09 | Dexcom, Inc. | Analyte sensor |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US6916159B2 (en) | 2002-10-09 | 2005-07-12 | Therasense, Inc. | Device and method employing shape memory alloy |
US7727181B2 (en) | 2002-10-09 | 2010-06-01 | Abbott Diabetes Care Inc. | Fluid delivery device with autocalibration |
US7993108B2 (en) | 2002-10-09 | 2011-08-09 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
US7248912B2 (en) * | 2002-10-31 | 2007-07-24 | The Regents Of The University Of California | Tissue implantable sensors for measurement of blood solutes |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
WO2004061420A2 (en) | 2002-12-31 | 2004-07-22 | Therasense, Inc. | Continuous glucose monitoring system and methods of use |
US7134999B2 (en) | 2003-04-04 | 2006-11-14 | Dexcom, Inc. | Optimized sensor geometry for an implantable glucose sensor |
US7679407B2 (en) | 2003-04-28 | 2010-03-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing peak detection circuitry for data communication systems |
ES2490740T3 (en) | 2003-06-06 | 2014-09-04 | Sanofi-Aventis Deutschland Gmbh | Apparatus for blood fluid sampling and analyte detection |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
US8275437B2 (en) | 2003-08-01 | 2012-09-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7778680B2 (en) | 2003-08-01 | 2010-08-17 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8788006B2 (en) | 2003-08-01 | 2014-07-22 | Dexcom, Inc. | System and methods for processing analyte sensor data |
EP1671096A4 (en) | 2003-09-29 | 2009-09-16 | Pelikan Technologies Inc | Method and apparatus for an improved sample capture device |
WO2005037095A1 (en) | 2003-10-14 | 2005-04-28 | Pelikan Technologies, Inc. | Method and apparatus for a variable user interface |
US8615282B2 (en) | 2004-07-13 | 2013-12-24 | Dexcom, Inc. | Analyte sensor |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
DE602004029092D1 (en) | 2003-12-05 | 2010-10-21 | Dexcom Inc | CALIBRATION METHODS FOR A CONTINUOUSLY WORKING ANALYTIC SENSOR |
US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
WO2005062765A2 (en) | 2003-12-18 | 2005-07-14 | Subq Llc | Implantable biosensor and methods of use thereof |
EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
CA2556331A1 (en) | 2004-02-17 | 2005-09-29 | Therasense, Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US8277713B2 (en) | 2004-05-03 | 2012-10-02 | Dexcom, Inc. | Implantable analyte sensor |
US8792955B2 (en) | 2004-05-03 | 2014-07-29 | Dexcom, Inc. | Transcutaneous analyte sensor |
WO2006011062A2 (en) | 2004-05-20 | 2006-02-02 | Albatros Technologies Gmbh & Co. Kg | Printable hydrogel for biosensors |
WO2005120365A1 (en) | 2004-06-03 | 2005-12-22 | Pelikan Technologies, Inc. | Method and apparatus for a fluid sampling device |
US20060015020A1 (en) * | 2004-07-06 | 2006-01-19 | Dexcom, Inc. | Systems and methods for manufacture of an analyte-measuring device including a membrane system |
US7522786B2 (en) | 2005-12-22 | 2009-04-21 | Palo Alto Research Center Incorporated | Transmitting light with photon energy information |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
WO2006102412A2 (en) | 2005-03-21 | 2006-09-28 | Abbott Diabetes Care, Inc. | Method and system for providing integrated medication infusion and analyte monitoring system |
US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
US7768408B2 (en) | 2005-05-17 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
US7620437B2 (en) | 2005-06-03 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
US7756561B2 (en) | 2005-09-30 | 2010-07-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
US7583190B2 (en) | 2005-10-31 | 2009-09-01 | Abbott Diabetes Care Inc. | Method and apparatus for providing data communication in data monitoring and management systems |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US7433552B2 (en) | 2005-12-22 | 2008-10-07 | Palo Alto Research Center Incorporated | Obtaining analyte information |
US8437582B2 (en) | 2005-12-22 | 2013-05-07 | Palo Alto Research Center Incorporated | Transmitting light with lateral variation |
US8344966B2 (en) | 2006-01-31 | 2013-01-01 | Abbott Diabetes Care Inc. | Method and system for providing a fault tolerant display unit in an electronic device |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
DE102006020720A1 (en) * | 2006-05-04 | 2007-11-08 | Robert Bosch Gmbh | Interferometric measuring device for optical measurement on skin structures |
US8126554B2 (en) | 2006-05-17 | 2012-02-28 | Cardiac Pacemakers, Inc. | Implantable medical device with chemical sensor and related methods |
WO2007143225A2 (en) | 2006-06-07 | 2007-12-13 | Abbott Diabetes Care, Inc. | Analyte monitoring system and method |
US9867530B2 (en) | 2006-08-14 | 2018-01-16 | Volcano Corporation | Telescopic side port catheter device with imaging system and method for accessing side branch occlusions |
US8579853B2 (en) | 2006-10-31 | 2013-11-12 | Abbott Diabetes Care Inc. | Infusion devices and methods |
WO2008058084A2 (en) * | 2006-11-03 | 2008-05-15 | Volcano Corporation | Analyte sensore method and apparatus |
US9164037B2 (en) | 2007-01-26 | 2015-10-20 | Palo Alto Research Center Incorporated | Method and system for evaluation of signals received from spatially modulated excitation and emission to accurately determine particle positions and distances |
US8821799B2 (en) | 2007-01-26 | 2014-09-02 | Palo Alto Research Center Incorporated | Method and system implementing spatially modulated excitation or emission for particle characterization with enhanced sensitivity |
US7502123B2 (en) * | 2007-02-05 | 2009-03-10 | Palo Alto Research Center Incorporated | Obtaining information from optical cavity output light |
US7633629B2 (en) * | 2007-02-05 | 2009-12-15 | Palo Alto Research Center Incorporated | Tuning optical cavities |
US7471399B2 (en) * | 2007-02-05 | 2008-12-30 | Palo Alto Research Center Incorporated | Photosensing optical cavity output light |
US7936463B2 (en) | 2007-02-05 | 2011-05-03 | Palo Alto Research Center Incorporated | Containing analyte in optical cavity structures |
US7852490B2 (en) * | 2007-02-05 | 2010-12-14 | Palo Alto Research Center Incorporated | Implanting optical cavity structures |
US7545513B2 (en) * | 2007-02-05 | 2009-06-09 | Palo Alto Research Center Incorporated | Encoding optical cavity output light |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
EP2178442B1 (en) | 2007-07-12 | 2017-09-06 | Volcano Corporation | Catheter for in vivo imaging |
US9596993B2 (en) | 2007-07-12 | 2017-03-21 | Volcano Corporation | Automatic calibration systems and methods of use |
WO2009009802A1 (en) | 2007-07-12 | 2009-01-15 | Volcano Corporation | Oct-ivus catheter for concurrent luminal imaging |
US8320983B2 (en) | 2007-12-17 | 2012-11-27 | Palo Alto Research Center Incorporated | Controlling transfer of objects affecting optical characteristics |
US8373860B2 (en) | 2008-02-01 | 2013-02-12 | Palo Alto Research Center Incorporated | Transmitting/reflecting emanating light with time variation |
US8629981B2 (en) | 2008-02-01 | 2014-01-14 | Palo Alto Research Center Incorporated | Analyzers with time variation based on color-coded spatial modulation |
US8682408B2 (en) | 2008-03-28 | 2014-03-25 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8583204B2 (en) | 2008-03-28 | 2013-11-12 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US11730407B2 (en) | 2008-03-28 | 2023-08-22 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US20100022856A1 (en) * | 2008-07-28 | 2010-01-28 | Medtronic, Inc. | Implantable optical hemodynamic sensor including light transmission member |
US9161714B2 (en) * | 2008-08-21 | 2015-10-20 | Palo Alto Research Center Incorporated | Specificity of analyte detection in etalons |
US7961326B2 (en) * | 2008-08-21 | 2011-06-14 | Palo Alto Research Center Incorporated | Method of detecting the concentration of an analyte |
EP3795987B1 (en) | 2008-09-19 | 2023-10-25 | Dexcom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US8560082B2 (en) | 2009-01-30 | 2013-10-15 | Abbott Diabetes Care Inc. | Computerized determination of insulin pump therapy parameters using real time and retrospective data processing |
WO2010123521A1 (en) | 2009-04-21 | 2010-10-28 | The Trustees Of Columbia University In The City Of New York | Sensors for long-term and continuous monitoring of biochemicals |
WO2010129375A1 (en) | 2009-04-28 | 2010-11-11 | Abbott Diabetes Care Inc. | Closed loop blood glucose control algorithm analysis |
US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
WO2010138856A1 (en) | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
EP3173014B1 (en) | 2009-07-23 | 2021-08-18 | Abbott Diabetes Care, Inc. | Real time management of data relating to physiological control of glucose levels |
US8993331B2 (en) | 2009-08-31 | 2015-03-31 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
EP2473098A4 (en) | 2009-08-31 | 2014-04-09 | Abbott Diabetes Care Inc | Analyte signal processing device and methods |
WO2011041469A1 (en) | 2009-09-29 | 2011-04-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
AU2011217068B2 (en) | 2010-02-16 | 2014-11-06 | Lightship Medical Limited | Barrier layer for glucose sensor |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US11141063B2 (en) | 2010-12-23 | 2021-10-12 | Philips Image Guided Therapy Corporation | Integrated system architectures and methods of use |
US11040140B2 (en) | 2010-12-31 | 2021-06-22 | Philips Image Guided Therapy Corporation | Deep vein thrombosis therapeutic methods |
EP3906842A1 (en) | 2011-07-26 | 2021-11-10 | Glysens Incorporated | Tissue implantable sensor with hermetically sealed housing |
WO2013019714A1 (en) | 2011-07-29 | 2013-02-07 | The Trustees Of Columbia University In The City Of New York | Mems affinity sensor for continuous monitoring of analytes |
US8723140B2 (en) | 2011-08-09 | 2014-05-13 | Palo Alto Research Center Incorporated | Particle analyzer with spatial modulation and long lifetime bioprobes |
US9029800B2 (en) | 2011-08-09 | 2015-05-12 | Palo Alto Research Center Incorporated | Compact analyzer with spatial modulation and multiple intensity modulated excitation sources |
US9360630B2 (en) | 2011-08-31 | 2016-06-07 | Volcano Corporation | Optical-electrical rotary joint and methods of use |
EP3677182B1 (en) | 2011-11-07 | 2022-05-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US10561353B2 (en) | 2016-06-01 | 2020-02-18 | Glysens Incorporated | Biocompatible implantable sensor apparatus and methods |
US10660550B2 (en) | 2015-12-29 | 2020-05-26 | Glysens Incorporated | Implantable sensor apparatus and methods |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US9743871B2 (en) * | 2012-09-24 | 2017-08-29 | Dexcom, Inc. | Multiple electrode system for a continuous analyte sensor, and related methods |
US9307926B2 (en) | 2012-10-05 | 2016-04-12 | Volcano Corporation | Automatic stent detection |
US9286673B2 (en) | 2012-10-05 | 2016-03-15 | Volcano Corporation | Systems for correcting distortions in a medical image and methods of use thereof |
US9858668B2 (en) | 2012-10-05 | 2018-01-02 | Volcano Corporation | Guidewire artifact removal in images |
US10568586B2 (en) | 2012-10-05 | 2020-02-25 | Volcano Corporation | Systems for indicating parameters in an imaging data set and methods of use |
US9478940B2 (en) | 2012-10-05 | 2016-10-25 | Volcano Corporation | Systems and methods for amplifying light |
US9292918B2 (en) | 2012-10-05 | 2016-03-22 | Volcano Corporation | Methods and systems for transforming luminal images |
US9324141B2 (en) | 2012-10-05 | 2016-04-26 | Volcano Corporation | Removal of A-scan streaking artifact |
US9367965B2 (en) | 2012-10-05 | 2016-06-14 | Volcano Corporation | Systems and methods for generating images of tissue |
US11272845B2 (en) | 2012-10-05 | 2022-03-15 | Philips Image Guided Therapy Corporation | System and method for instant and automatic border detection |
US10070827B2 (en) | 2012-10-05 | 2018-09-11 | Volcano Corporation | Automatic image playback |
US9840734B2 (en) | 2012-10-22 | 2017-12-12 | Raindance Technologies, Inc. | Methods for analyzing DNA |
WO2014093374A1 (en) | 2012-12-13 | 2014-06-19 | Volcano Corporation | Devices, systems, and methods for targeted cannulation |
EP2934310A4 (en) | 2012-12-20 | 2016-10-12 | Nathaniel J Kemp | Optical coherence tomography system that is reconfigurable between different imaging modes |
US9730613B2 (en) | 2012-12-20 | 2017-08-15 | Volcano Corporation | Locating intravascular images |
EP2934311B1 (en) | 2012-12-20 | 2020-04-15 | Volcano Corporation | Smooth transition catheters |
US11406498B2 (en) | 2012-12-20 | 2022-08-09 | Philips Image Guided Therapy Corporation | Implant delivery system and implants |
US10939826B2 (en) | 2012-12-20 | 2021-03-09 | Philips Image Guided Therapy Corporation | Aspirating and removing biological material |
US10942022B2 (en) | 2012-12-20 | 2021-03-09 | Philips Image Guided Therapy Corporation | Manual calibration of imaging system |
US9486143B2 (en) | 2012-12-21 | 2016-11-08 | Volcano Corporation | Intravascular forward imaging device |
US10058284B2 (en) | 2012-12-21 | 2018-08-28 | Volcano Corporation | Simultaneous imaging, monitoring, and therapy |
US10420530B2 (en) | 2012-12-21 | 2019-09-24 | Volcano Corporation | System and method for multipath processing of image signals |
WO2014099760A1 (en) | 2012-12-21 | 2014-06-26 | Mai Jerome | Ultrasound imaging with variable line density |
WO2014100530A1 (en) | 2012-12-21 | 2014-06-26 | Whiseant Chester | System and method for catheter steering and operation |
WO2014100606A1 (en) | 2012-12-21 | 2014-06-26 | Meyer, Douglas | Rotational ultrasound imaging catheter with extended catheter body telescope |
US9612105B2 (en) | 2012-12-21 | 2017-04-04 | Volcano Corporation | Polarization sensitive optical coherence tomography system |
JP2016508757A (en) | 2012-12-21 | 2016-03-24 | ジェイソン スペンサー, | System and method for graphical processing of medical data |
JP2016508233A (en) | 2012-12-21 | 2016-03-17 | ナサニエル ジェイ. ケンプ, | Power efficient optical buffering using optical switches |
JP2016507892A (en) | 2012-12-21 | 2016-03-10 | デイビッド ウェルフォード, | System and method for narrowing the wavelength emission of light |
US9770172B2 (en) | 2013-03-07 | 2017-09-26 | Volcano Corporation | Multimodal segmentation in intravascular images |
US10226597B2 (en) | 2013-03-07 | 2019-03-12 | Volcano Corporation | Guidewire with centering mechanism |
JP2016521138A (en) | 2013-03-12 | 2016-07-21 | コリンズ,ドナ | System and method for diagnosing coronary microvascular disease |
US20140276923A1 (en) | 2013-03-12 | 2014-09-18 | Volcano Corporation | Vibrating catheter and methods of use |
EP2967488B1 (en) | 2013-03-13 | 2021-06-16 | Jinhyoung Park | System for producing an image from a rotational intravascular ultrasound device |
US9301687B2 (en) | 2013-03-13 | 2016-04-05 | Volcano Corporation | System and method for OCT depth calibration |
US11026591B2 (en) | 2013-03-13 | 2021-06-08 | Philips Image Guided Therapy Corporation | Intravascular pressure sensor calibration |
US10219887B2 (en) | 2013-03-14 | 2019-03-05 | Volcano Corporation | Filters with echogenic characteristics |
JP6342984B2 (en) | 2013-03-14 | 2018-06-13 | ボルケーノ コーポレイション | Filter with echogenic properties |
US10292677B2 (en) | 2013-03-14 | 2019-05-21 | Volcano Corporation | Endoluminal filter having enhanced echogenic properties |
WO2016022696A1 (en) | 2014-08-05 | 2016-02-11 | The Trustees Of Columbia University In The City Of New York | Method of isolating aptamers for minimal residual disease detection |
US10780222B2 (en) | 2015-06-03 | 2020-09-22 | Pacific Diabetes Technologies Inc | Measurement of glucose in an insulin delivery catheter by minimizing the adverse effects of insulin preservatives |
US10716500B2 (en) | 2015-06-29 | 2020-07-21 | Cardiac Pacemakers, Inc. | Systems and methods for normalization of chemical sensor data based on fluid state changes |
CA2996053A1 (en) * | 2015-09-02 | 2017-03-09 | Metronom Health, Inc. | Systems and methods for continuous health monitoring using an opto-enzymatic analyte sensor |
US10638962B2 (en) | 2016-06-29 | 2020-05-05 | Glysens Incorporated | Bio-adaptable implantable sensor apparatus and methods |
US10332693B2 (en) | 2016-07-15 | 2019-06-25 | Nanotek Instruments, Inc. | Humic acid-based supercapacitors |
US11254616B2 (en) | 2016-08-04 | 2022-02-22 | Global Graphene Group, Inc. | Method of producing integral 3D humic acid-carbon hybrid foam |
US10731931B2 (en) | 2016-08-18 | 2020-08-04 | Global Graphene Group, Inc. | Highly oriented humic acid films and highly conducting graphitic films derived therefrom and devices containing same |
US10597389B2 (en) | 2016-08-22 | 2020-03-24 | Global Graphene Group, Inc. | Humic acid-bonded metal foil film current collector and battery and supercapacitor containing same |
WO2018038920A1 (en) * | 2016-08-26 | 2018-03-01 | Cardiac Pacemakers, Inc. | Systems and methods for determining presence of an analyte using an implantable medical device |
US10647595B2 (en) | 2016-08-30 | 2020-05-12 | Global Graphene Group, Inc. | Humic acid-derived conductive foams and devices |
US11638544B2 (en) * | 2017-05-17 | 2023-05-02 | Radiometer Medical Aps | Porous optical fiber for the detection of an analyte in a fluid |
CN108968976B (en) | 2017-05-31 | 2022-09-13 | 心脏起搏器股份公司 | Implantable medical device with chemical sensor |
US10638979B2 (en) | 2017-07-10 | 2020-05-05 | Glysens Incorporated | Analyte sensor data evaluation and error reduction apparatus and methods |
CN109381195B (en) | 2017-08-10 | 2023-01-10 | 心脏起搏器股份公司 | Systems and methods including electrolyte sensor fusion |
CN109419515B (en) | 2017-08-23 | 2023-03-24 | 心脏起搏器股份公司 | Implantable chemical sensor with staged activation |
CN109864746B (en) | 2017-12-01 | 2023-09-29 | 心脏起搏器股份公司 | Multimode analyte sensor for medical devices |
CN109864747B (en) | 2017-12-05 | 2023-08-25 | 心脏起搏器股份公司 | Multimode analyte sensor optoelectronic interface |
US11278668B2 (en) | 2017-12-22 | 2022-03-22 | Glysens Incorporated | Analyte sensor and medicant delivery data evaluation and error reduction apparatus and methods |
US11255839B2 (en) | 2018-01-04 | 2022-02-22 | Glysens Incorporated | Apparatus and methods for analyte sensor mismatch correction |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US426358A (en) | 1890-04-22 | Brazing-machine | ||
EP0074428A1 (en) | 1981-09-15 | 1983-03-23 | Arno Dr. Dipl.-Phys. Müller | Method and device for the quantitative determination of dissolved substances in single- or multicomponent systems of laser light scattering |
EP0160768A1 (en) | 1984-05-04 | 1985-11-13 | Kurabo Industries Ltd. | Spectrophotometric apparatus for the non-invasive determination of glucose in body tissues |
WO1993000856A1 (en) | 1991-07-03 | 1993-01-21 | Vivascan Corporation | A non-invasive method and apparatus for measuring concentration of analytes in living tissue |
US5551422A (en) | 1992-11-09 | 1996-09-03 | Boehringer Mannheim Gmbh | Method and apparatus for analytical determination of glucose in a biological matrix |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4024043A (en) | 1975-12-31 | 1977-05-17 | Allied Chemical Corporation | Single film, high performance bipolar membrane |
AU1615983A (en) | 1982-06-22 | 1984-01-05 | Unsearch Ltd. | Bipolar membrane |
US4584246A (en) | 1983-11-23 | 1986-04-22 | Chinese Petroleum Corp. | Bipolar membranes |
DE3508206A1 (en) | 1985-03-08 | 1986-09-11 | Basf Ag, 6700 Ludwigshafen | METHOD FOR PRODUCING BIPOLAR MEMBRANES |
US5227040A (en) * | 1987-07-30 | 1993-07-13 | Unisearch Limited | High performance bipolar membranes |
US5098532A (en) | 1991-05-24 | 1992-03-24 | Ormiston Mining And Smelting Co. Ltd. | Process for producing sodium hydroxide and ammonium sulfate from sodium sulfate |
US5246551A (en) | 1992-02-11 | 1993-09-21 | Chemetics International Company Ltd. | Electrochemical methods for production of alkali metal hydroxides without the co-production of chlorine |
WO1994010553A1 (en) | 1992-10-23 | 1994-05-11 | Optex Biomedical, Inc. | Fibre-optic probe for the measurement of fluid parameters |
DE19521628A1 (en) * | 1995-06-14 | 1997-01-09 | Hoechst Ag | Optical probe with sensor made of an optical polymer |
EP0955865B1 (en) * | 1995-07-21 | 2005-09-28 | Respironics, Inc. | Apparatus for diode laser pulse oximetry using multifiber optical cables and disposable fiber optic probes |
US6095974A (en) * | 1995-07-21 | 2000-08-01 | Respironics, Inc. | Disposable fiber optic probe |
DE19540456C2 (en) | 1995-10-30 | 1997-10-09 | Buschmann Johannes | Method of measuring glucose concentration in a liquid and use of the method |
JP2000500656A (en) * | 1995-11-22 | 2000-01-25 | ミニメッド インコーポレイティド | Detection of biomolecules using chemical amplification and optical sensors |
IL127213A (en) | 1996-07-08 | 2003-09-17 | Animas Corp | Implantable sensor and system for in vivo measurement and control of fluid constituent levels |
US6070093A (en) | 1997-12-02 | 2000-05-30 | Abbott Laboratories | Multiplex sensor and method of use |
US6241663B1 (en) * | 1998-05-18 | 2001-06-05 | Abbott Laboratories | Method for improving non-invasive determination of the concentration of analytes in a biological sample |
ES2306525T3 (en) | 1998-08-26 | 2008-11-01 | Sensors For Medicine And Science, Inc. | OPTICAL-BASED DETECTION DEVICES. |
JP4055266B2 (en) * | 1998-10-13 | 2008-03-05 | 株式会社日立製作所 | Optical measuring device |
US6442410B1 (en) * | 1999-06-10 | 2002-08-27 | Georgia Tech Research Corp. | Non-invasive blood glucose measurement system and method using optical refractometry |
US6952603B2 (en) * | 2001-03-16 | 2005-10-04 | Roche Diagnostics Operations, Inc. | Subcutaneous analyte sensor |
-
2001
- 2001-03-16 US US09/810,635 patent/US6952603B2/en not_active Expired - Fee Related
-
2002
- 2002-03-18 AU AU2002237332A patent/AU2002237332A1/en not_active Abandoned
- 2002-03-18 WO PCT/EP2002/002960 patent/WO2002074161A2/en active Application Filing
- 2002-03-18 JP JP2002572876A patent/JP3692116B2/en not_active Expired - Lifetime
- 2002-03-18 EP EP02703638A patent/EP1372466A2/en not_active Withdrawn
- 2002-03-18 CA CA 2440854 patent/CA2440854C/en not_active Expired - Fee Related
-
2005
- 2005-04-27 US US11/115,889 patent/US7499738B2/en not_active Expired - Fee Related
- 2005-04-27 US US11/116,099 patent/US20050271547A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US426358A (en) | 1890-04-22 | Brazing-machine | ||
EP0074428A1 (en) | 1981-09-15 | 1983-03-23 | Arno Dr. Dipl.-Phys. Müller | Method and device for the quantitative determination of dissolved substances in single- or multicomponent systems of laser light scattering |
EP0160768A1 (en) | 1984-05-04 | 1985-11-13 | Kurabo Industries Ltd. | Spectrophotometric apparatus for the non-invasive determination of glucose in body tissues |
WO1993000856A1 (en) | 1991-07-03 | 1993-01-21 | Vivascan Corporation | A non-invasive method and apparatus for measuring concentration of analytes in living tissue |
US5551422A (en) | 1992-11-09 | 1996-09-03 | Boehringer Mannheim Gmbh | Method and apparatus for analytical determination of glucose in a biological matrix |
Cited By (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10722152B2 (en) | 2004-07-13 | 2020-07-28 | Dexcom, Inc. | Analyte sensor |
US10932700B2 (en) | 2004-07-13 | 2021-03-02 | Dexcom, Inc. | Analyte sensor |
US11883164B2 (en) | 2004-07-13 | 2024-01-30 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US11064917B2 (en) | 2004-07-13 | 2021-07-20 | Dexcom, Inc. | Analyte sensor |
US11045120B2 (en) | 2004-07-13 | 2021-06-29 | Dexcom, Inc. | Analyte sensor |
US11026605B1 (en) | 2004-07-13 | 2021-06-08 | Dexcom, Inc. | Analyte sensor |
US10709362B2 (en) | 2004-07-13 | 2020-07-14 | Dexcom, Inc. | Analyte sensor |
US10918313B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US10918315B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US10524703B2 (en) | 2004-07-13 | 2020-01-07 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10993642B2 (en) | 2004-07-13 | 2021-05-04 | Dexcom, Inc. | Analyte sensor |
US10993641B2 (en) | 2004-07-13 | 2021-05-04 | Dexcom, Inc. | Analyte sensor |
US10799159B2 (en) | 2004-07-13 | 2020-10-13 | Dexcom, Inc. | Analyte sensor |
US10799158B2 (en) | 2004-07-13 | 2020-10-13 | Dexcom, Inc. | Analyte sensor |
US10813576B2 (en) | 2004-07-13 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
US10980452B2 (en) | 2004-07-13 | 2021-04-20 | Dexcom, Inc. | Analyte sensor |
US10827956B2 (en) | 2004-07-13 | 2020-11-10 | Dexcom, Inc. | Analyte sensor |
US9986942B2 (en) | 2004-07-13 | 2018-06-05 | Dexcom, Inc. | Analyte sensor |
US10918314B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US10709363B2 (en) | 2004-07-13 | 2020-07-14 | Dexcom, Inc. | Analyte sensor |
US10716498B2 (en) | 2005-03-10 | 2020-07-21 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10709364B2 (en) | 2005-03-10 | 2020-07-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918316B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918317B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10898114B2 (en) | 2005-03-10 | 2021-01-26 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10925524B2 (en) | 2005-03-10 | 2021-02-23 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10856787B2 (en) | 2005-03-10 | 2020-12-08 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610136B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10743801B2 (en) | 2005-03-10 | 2020-08-18 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918318B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US11000213B2 (en) | 2005-03-10 | 2021-05-11 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10617336B2 (en) | 2005-03-10 | 2020-04-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610135B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US11051726B2 (en) | 2005-03-10 | 2021-07-06 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610137B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10813577B2 (en) | 2005-06-21 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
US11102306B2 (en) | 2008-02-21 | 2021-08-24 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
Also Published As
Publication number | Publication date |
---|---|
US20020161286A1 (en) | 2002-10-31 |
CA2440854C (en) | 2008-08-05 |
US7499738B2 (en) | 2009-03-03 |
US20050271547A1 (en) | 2005-12-08 |
WO2002074161A3 (en) | 2003-07-24 |
US20050271546A1 (en) | 2005-12-08 |
JP3692116B2 (en) | 2005-09-07 |
JP2004526497A (en) | 2004-09-02 |
AU2002237332A1 (en) | 2002-10-03 |
EP1372466A2 (en) | 2004-01-02 |
US6952603B2 (en) | 2005-10-04 |
CA2440854A1 (en) | 2002-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2440854C (en) | Subcutaneous analyte sensor | |
US7315752B2 (en) | Method and device for determining a light transport parameter in a biological matrix | |
Mansouri et al. | A miniature optical glucose sensor based on affinity binding | |
US5039492A (en) | Optical pH and gas concentration sensor | |
US20120059232A1 (en) | Implantable optical glucose sensing | |
US5176882A (en) | Dual fiberoptic cell for multiple serum measurements | |
US7824902B2 (en) | Optical interface for disposable bioreactors | |
US8160665B2 (en) | Microneedle arrays with ATR sensor | |
US20040147034A1 (en) | Method and apparatus for measuring a substance in a biological sample | |
JP3396222B2 (en) | Apparatus for analytical determination of glucose concentration in biological matrices | |
US8173439B2 (en) | Measurement system with optical referencing | |
US20130006069A1 (en) | Implantable optical glucose sensing | |
CA2352201A1 (en) | Non-invasive sensor capable of determining optical parameters in a sample having multiple layers | |
JP2001513350A (en) | Analytical device for in vivo analysis in a patient's body | |
CA2457753A1 (en) | Measuring a substance in a biological sample | |
McShane et al. | Monte Carlo modeling for implantable fluorescent analyte sensors | |
CN101947115A (en) | Implantable human blood glucose concentration continuous monitoring system based on optical fiber attenuation total reflection | |
US10925528B2 (en) | Depth scanning oxygen sensor | |
US20150253333A1 (en) | Cellarium: glucose, ph, and oxygen triple sensor | |
Walt | Fiber-optic sensors for continuous clinical monitoring | |
US20150247797A1 (en) | Microchannel plasmon resonance biosensor | |
ES2630755T3 (en) | In vitro sensor for the point of care and use procedure | |
RU2730438C2 (en) | Whole blood so2 sensor | |
US20080050768A1 (en) | Metabolic Monitoring Device | |
WO1992011801A1 (en) | Method and sensor for detecting specific parameters of circulating blood inside a living organism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002703638 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002572876 Country of ref document: JP Ref document number: 2440854 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 2002703638 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |